Guardian Pharmacy Services
GRDN
40.68
-0.52
-1.26%
Guardian Pharmacy Services
US · GRDN
#2584 by market cap
Listed 2024
40.68
-0.52
-1.26%
Live - 5344 symbols - heartbeat 61s ago
· 2026-10-07 19:54
After-hours
40.68
0.00%
- Market cap
- 2.58B
- P/E (TTM)i
- 39.12
- P/Bi
- 10.49
- EPSi
- 0.78
- Div yieldi
- 0.00%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on GRDN?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Analysts Offer Insights on NA Companies: Emerson Electric Company (EMR), Omada Health, Inc. (OMDA) and Guardian Pharmacy Services, Inc. Class A (GRDN)TipRanks · 2026/8/7
-
Rating change
Oppenheimer Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $49Market Newswire · 2026/8/7
-
Earnings Flash (GRDN) Guardian Pharmacy Services, Inc. Reports Q2 Revenue $351.8M, Vs. FactSet Est of $340.4MMT Newswires · 2026/8/7
-
Rating change
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Guardian Pharmacy Services, Inc. Class A (GRDN) and Alto Neuroscience, Inc. (ANRO)TipRanks · 2026/6/17
-
Rating change
Stephens Remains a Buy on Guardian Pharmacy Services, Inc. Class A (GRDN)TipRanks · 2026/8/7
-
Rating change
Stephens Keeps Their Buy Rating on Guardian Pharmacy Services, Inc. Class A (GRDN)TipRanks · 2026/6/23
-
Rating change
Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $47Market Newswire · 2026/6/17
-
Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $51Market Newswire · 2026/9/21
-
Rating change
Oppenheimer Sticks to Its Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)TipRanks · 2026/8/7
-
Rating change
Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy RatingMarket Newswire · 2026/8/7
-
Rating change
Truist Financial Sticks to Their Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)TipRanks · 2026/6/23
-
Rating change
BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $47Market Newswire · 2026/8/7
-
Rating change
BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy RatingMarket Newswire · 2026/7/2
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN)TipRanks · 2026/7/2
-
Rating change
Analysts' Top Healthcare Picks: Diamedica Therapeutics (DMAC), Guardian Pharmacy Services, Inc. Class A (GRDN)TipRanks · 2026/6/23
-
Analysts Conflicted on These NA Names: Starz Entertainment Corp (STRZ), Guardian Pharmacy Services, Inc. Class A (GRDN) and MSC Income Fund, Inc. (MSIF)TipRanks · 2026/8/8
-
Rating change
BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $47Market Newswire · 2026/6/17
-
KeyBanc Initiates Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $52Market Newswire · 2026/9/23
-
Rating change
Truist Financial Initiates Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $47Market Newswire · 2026/6/23
-
BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Maintains Target Price $47Market Newswire · 2026/9/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.